Modulation of purinergic signaling in endothelial cells by tumor microenvironment

IF 3.5 3区 医学 Q2 PHARMACOLOGY & PHARMACY Vascular pharmacology Pub Date : 2024-06-01 DOI:10.1016/j.vph.2024.107311
Giorgia Chinigò , Giorgia Scarpellino , Sara Petrillo , Tullio Genova , Federico Alessandro Ruffinatti , Luca Munaron
{"title":"Modulation of purinergic signaling in endothelial cells by tumor microenvironment","authors":"Giorgia Chinigò ,&nbsp;Giorgia Scarpellino ,&nbsp;Sara Petrillo ,&nbsp;Tullio Genova ,&nbsp;Federico Alessandro Ruffinatti ,&nbsp;Luca Munaron","doi":"10.1016/j.vph.2024.107311","DOIUrl":null,"url":null,"abstract":"<div><p>Purinergic signaling plays a crucial role in vascular endothelium functions. In particular, ionotropic P2X receptors (P2XRs) are engaged in various intracellular pathways through which endothelial cells (ECs) adapt to external stimuli. However, very little is known about the impact of P2XRs on vascular remodeling during carcinogenesis.</p><p>We previously demonstrated that high purinergic stimulation impairs the migratory phenotype of tumor-derived endothelial cells (TECs) but not of normal ECs.</p><p>Since P2XRs are sensitive to different physical and chemical factors, we investigated the impact of tumor microenvironment (TME) on healthy ECs to verify the ability of cancer cells to affect endothelial migratory phenotype through purinergic signaling tuning. More specifically, we focused on P2XR modulation by two different types of TME, mimicking breast and pancreas cancer milieux, which show very different features in terms of vascularization and composition. ECs conditioning with both cancer cell types induced a significant upregulation of some of the most represented P2XR. However, only conditioning with MCF-7 cells and not that with PANC-1 cells was able to alter the migratory phenotype of normal ECs supporting a P2XR-mediated inhibition of cell migration. The differences observed between the two cancer cells could be due to their different proliferative potential and the subsequent different extracellular pH. In addition, in agreement with some of our previous data, the P2XR-induced inhibition of EC migration seems to be independent of calcium signals, as conditioned ECs didn't reveal any changes in the long-lasting responses evoked by purinergic agonists.</p><p>Collectively, highlighting a significant P2RX modulation by TME, our data strengthen the hypothesis that purinergic signaling may play a central role in vascular remodeling during carcinogenesis. However, the molecular routes upstream and downstream of this modulation remain to be elucidated.</p></div>","PeriodicalId":23949,"journal":{"name":"Vascular pharmacology","volume":null,"pages":null},"PeriodicalIF":3.5000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1537189124000363","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Purinergic signaling plays a crucial role in vascular endothelium functions. In particular, ionotropic P2X receptors (P2XRs) are engaged in various intracellular pathways through which endothelial cells (ECs) adapt to external stimuli. However, very little is known about the impact of P2XRs on vascular remodeling during carcinogenesis.

We previously demonstrated that high purinergic stimulation impairs the migratory phenotype of tumor-derived endothelial cells (TECs) but not of normal ECs.

Since P2XRs are sensitive to different physical and chemical factors, we investigated the impact of tumor microenvironment (TME) on healthy ECs to verify the ability of cancer cells to affect endothelial migratory phenotype through purinergic signaling tuning. More specifically, we focused on P2XR modulation by two different types of TME, mimicking breast and pancreas cancer milieux, which show very different features in terms of vascularization and composition. ECs conditioning with both cancer cell types induced a significant upregulation of some of the most represented P2XR. However, only conditioning with MCF-7 cells and not that with PANC-1 cells was able to alter the migratory phenotype of normal ECs supporting a P2XR-mediated inhibition of cell migration. The differences observed between the two cancer cells could be due to their different proliferative potential and the subsequent different extracellular pH. In addition, in agreement with some of our previous data, the P2XR-induced inhibition of EC migration seems to be independent of calcium signals, as conditioned ECs didn't reveal any changes in the long-lasting responses evoked by purinergic agonists.

Collectively, highlighting a significant P2RX modulation by TME, our data strengthen the hypothesis that purinergic signaling may play a central role in vascular remodeling during carcinogenesis. However, the molecular routes upstream and downstream of this modulation remain to be elucidated.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肿瘤微环境对内皮细胞嘌呤能信号的调控
嘌呤能信号在血管内皮功能中起着至关重要的作用。特别是,离子型 P2X 受体(P2XRs)参与了内皮细胞(ECs)适应外部刺激的各种细胞内途径。由于 P2XRs 对不同的物理和化学因素敏感,我们研究了肿瘤微环境(TME)对健康 EC 的影响,以验证癌细胞通过嘌呤能信号调节影响内皮迁移表型的能力。更具体地说,我们重点研究了两种不同类型的 TME 对 P2XR 的调节作用,它们分别模拟了乳腺癌和胰腺癌的环境,这两种癌症在血管化和组成方面表现出截然不同的特征。用这两种癌细胞类型调节心血管细胞会诱导一些最具代表性的 P2XR 显著上调。不过,只有 MCF-7 细胞而非 PANC-1 细胞能改变正常心肌细胞的迁移表型,支持 P2XR 介导的细胞迁移抑制作用。在两种癌细胞之间观察到的差异可能是由于它们的增殖潜力不同以及随后的细胞外 pH 值不同造成的。此外,与我们之前的一些数据一致的是,P2XR 诱导的心肌细胞迁移抑制似乎与钙信号无关,因为条件性心肌细胞在嘌呤能激动剂诱发的持久反应中没有显示出任何变化。然而,这种调节的上下游分子途径仍有待阐明。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Vascular pharmacology
Vascular pharmacology 医学-药学
CiteScore
6.60
自引率
2.50%
发文量
153
审稿时长
31 days
期刊介绍: Vascular Pharmacology publishes papers, which contains results of all aspects of biology and pharmacology of the vascular system. Papers are encouraged in basic, translational and clinical aspects of Vascular Biology and Pharmacology, utilizing approaches ranging from molecular biology to integrative physiology. All papers are in English. The Journal publishes review articles which include vascular aspects of thrombosis, inflammation, cell signalling, atherosclerosis, and lipid metabolism.
期刊最新文献
Functional characterization of human IL-8 in vascular stenosis using a novel humanized transgenic mouse model Lack of AMP-activated protein kinase-α1 reduces nitric oxide synthesis in thoracic aorta perivascular adipose tissue Different gene expression patterns between mouse and human brain pericytes revealed by single-cell/nucleus RNA sequencing Bioactive lipids improve serum HDL and PON1 activities in coronary artery disease patients: Ex-vivo study Examining the controversies in venous thromboembolism prophylaxis for vascular surgery patients: A critical review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1